Related Experiment Video

Updated: Aug 7, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

[Systemic sclerosis: symptomatic treatment]

Bozena Dziankowska-Bartkowiak1, Elzbieta Waszczykowska, Kamila Skretkowicz

  • 1Samodzielna Pracownia Immunodermatologii Katedry i Kliniki Dermatologii i Wenerologii Akademii Medycznej w Łodzi.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|December 19, 2003
PubMed

Insights

Systemic sclerosis is a difficult autoimmune disease causing fibrosis. This paper reviews current and novel treatments targeting its complex pathogenesis and multi-systemic effects.

Area of Science:

  • Rheumatology
  • Immunology
  • Pathophysiology

Context:

  • Systemic sclerosis is an autoimmune connective tissue disease characterized by fibrosis affecting skin and internal organs.
  • Its pathogenesis involves complex interactions of genetic and environmental factors, leading to immune activation, vascular issues, and excessive collagen deposition.

Purpose:

  • To review established and emerging therapies for systemic sclerosis.
  • To provide insights into managing this challenging condition based on its underlying pathogenesis.

Summary:

  • Treatment strategies for systemic sclerosis aim to address immune activation, vascular abnormalities, and fibrosis.
  • Therapies include vasoactive drugs, antifibrotic agents, immunosuppression, and symptomatic relief.

Impact:

  • Offers a comprehensive overview of systemic sclerosis treatments for clinicians and researchers.
  • Highlights the need for targeted therapies due to the disease's multi-systemic impact on digestive, pulmonary, cardiovascular, neuromuscular, and locomotor systems.

More Related Videos

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Warm Moxibustion and Scraping as a Traditional Chinese Medicine Therapy for Cervical Spondylosis Treatment04:28

Warm Moxibustion and Scraping as a Traditional Chinese Medicine Therapy for Cervical Spondylosis Treatment

Published on: June 27, 2025

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...